Journal
EUROPEAN NEUROLOGY
Volume 72, Issue -, Pages 26-38Publisher
KARGER
DOI: 10.1159/000367621
Keywords
Multiple sclerosis; Pediatrics; Disease-modifying therapy
Categories
Funding
- Laboratorios Almirall, SA (Barcelona, Spain)